| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.0097 |
0.9 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.9 |
| mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.01 |
0.9 |